Inventor
VERHOEVEN THOMAS R
US35 patents
⚠️ This page may combine multiple inventors who share the name “VERHOEVEN THOMAS R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
32 patentsUS4820850AApr 11, 1989
Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
MERCK & CO INC154 citations99
US4582915AApr 15, 1986
Process for C-methylation of 2-methylbutyrates
MERCK & CO INC61 citations96
US4611067ASep 9, 1986
Process for the preparation of HMG-CoA reductase inhibitors and intermediate compounds employed therein
MERCK & CO INC57 citations95
US5399771AMar 21, 1995
Process of synthesizing binaphthyl derivatives
MERCK & CO INC37 citations92
US5834502ANov 10, 1998
Triazolylmethyl-indole ethylamine bisulfate salt
MERCK & CO INC18 citations88
US4645854AFeb 24, 1987
Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit
MERCK & CO INC22 citations81
US4620025AOct 28, 1986
Process for the preparation of biphenyl intermediates
MERCK & CO INC13 citations74
US4584389AApr 22, 1986
Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
MERCK & CO INC9 citations74
US5596113AJan 21, 1997
Ruthenium-phosphine complex catalysts for asymmetric hydrogenations
MERCK & CO INC12 citations72
US5567824AOct 22, 1996
Palladium catalyzed ring closure of triazolyltryptamine
MERCK & CO INC16 citations72
US5424432AJun 13, 1995
Process for the preparation of imidazolutidine
MERCK & CO INC17 citations71
US5508435AApr 16, 1996
Asymmetric hydrogenation of beta- or gamma-ketoesters and beta- or gamma-ketoamides
MERCK & CO INC14 citations70
US6333435B1Dec 25, 2001
Process of synthesizing binaphthyl derivatives
MERCK & CO INC12 citations69
US5420353AMay 30, 1995
Regiospecific process to make cis-1-amino-2-alkanol from epoxide
MERCK & CO INC8 citations69
US5693816ADec 2, 1997
Process for the preparation of diisopinocampheylchloroborane
MERCK & CO INC5 citations68
US5292946AMar 8, 1994
In-situ preparation of diisopinocamphenyl chloroborane
MERCK & CO INC10 citations68
US5858737AJan 12, 1999
Conversion of indene to (1S)-amino-(2R)-indanol free of any stereoisomer, by combination of dioxygenase bioconversion and chemical steps
MERCK & CO INC6 citations67
US4866186ASep 12, 1989
Process for the formation of 6-desmethyl-6-exo-methylene derivatives of lovastatin and analogs thereof
MERCK & CO INC4 citations63
US4845237AJul 4, 1989
Acylation process for the synthesis of HMG-CoA reductase inhibitors
MERCK & CO INC4 citations62
US4582914AApr 15, 1986
Process for the preparation of HMG-CoA reductase inhibitors
MERCK & CO INC3 citations62
US5124448AJun 23, 1992
Deblocking process for allyl esters with regeneratable polymer supported Pd(O)
MERCK & CO INC5 citations61
US5545758AAug 13, 1996
Process for the preparation of diisopinocampheylchloroborane
MERCK & CO INC2 citations60
US5605819AFeb 25, 1997
Quantitative conversion of indene to (1S,2R) indene oxide and (1S,2R)-indandiol by combination of haloperoxidase bioconversion and chemical steps
MERCK & CO INC4 citations59
US4876364AOct 24, 1989
Hydrogenation process for the formation of 4A,5-dihydro HMG-CoA reductase inhibitors
MERCK & CO INC6 citations57
US4831165AMay 16, 1989
Hydrogenation process for the formation of 3,4-dihydro HMG-CoA reductase inhibitors
MERCK & CO INC4 citations57
US4697037ASep 29, 1987
Preparation of dibenzo[b,f]thiepin compounds
MERCK & CO INC0 citations52
US5489710AFeb 6, 1996
Regiospecific processes to make cis-1-amino-2-alkanol from diol
MERCK & CO INC1 citations51
US5484923AJan 16, 1996
Process of making spirocycles and analogs thereof
MERCK & CO INC1 citations51
US4864035ASep 5, 1989
Hydrogenation process for the formation of tetrahydro HMG-CoA reductase inhibitors
MERCK & CO INC1 citations51
US4826999AMay 2, 1989
Hydrogenation process for the formation of 3,5-dihydro HMG-CoA reductase inhibitors
MERCK & CO INC1 citations51
US5693812ADec 2, 1997
Polymorphic forms of an angiotensin II antagonist
MERCK & CO INC1 citations49
US5099033AMar 24, 1992
Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as PAF antagonists
MERCK & CO INC0 citations42